Rhythm Pharmaceuticals, Inc. (RYTM) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es RA CAPITAL MANAGEMENT, LLC con 5,422,312 acciones. Otros tenedores destacados incluyen RA CAPITAL MANAGEMENT, L.P. y THIRD ROCK VENTURES LP.
En los últimos 12 meses, los internos han realizado 57 transacciones en RYTM acciones — 19 compras (valoradas en $3.32M) y 11 ventas (valoradas en $2.56M). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
RYTM Participación de Insiders
Principal Titular
RA CAPITAL MANAGEMENT, LLC
5,422,312 acciones
Compras (12 meses)
19
$3.32M valor
Ventas (12 meses)
11
$2.56M valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Ra Capital Management, Llc |
10 Percent Owner |
5,422,312 |
2019-10-18 |
|
| 2 |
Ra Capital Management, L.p. |
Officer |
4,568,464 |
2020-12-04 |
|
| 3 |
Third Rock Ventures Lp |
10 Percent Owner |
2,981,437 |
2018-09-04 |
|
| 4 |
Orbimed Advisors Llc |
10 Percent Owner |
2,750,079 |
2018-05-24 |
|
| 5 |
Foley Todd |
Director |
909,258 |
2021-03-16 |
|
| 6 |
Gottesdiener Keith Michael |
CEO & President |
207,877 |
2020-03-11 |
|
| 7 |
Smith Hunter C |
Chief Financial Officer |
91,401 |
2026-03-02 |
|
| 8 |
Meeker David P |
President and CEO |
71,900 |
2026-02-13 |
|
| 9 |
Desikan Nithya |
Chief Commercial Officer |
43,602 |
2020-09-01 |
|
| 10 |
Fiedorek Fred T. |
Chief Medical Officer |
25,000 |
2018-02-16 |
|
| 11 |
Lee Jennifer Kayden |
EVP, Head of North America |
21,650 |
2026-02-13 |
|
| 12 |
Garfield Alastair |
Chief Scientific Officer |
16,650 |
2026-02-13 |
|
| 13 |
Shulman Joseph |
Chief Technical Officer |
15,000 |
2026-02-13 |
|
| 14 |
Mathers Edward T |
Director |
14,168 |
2026-03-16 |
|
| 15 |
Van Der Ploeg Leonardus H.t. |
Chief Scientific Officer |
13,611 |
2019-06-03 |
|
| 16 |
Manning Linda Shapiro |
Chief Medical Officer |
12,500 |
2022-02-11 |
|
| 17 |
Cramer Pamela J. |
Chief Human Resources Officer |
11,650 |
2026-02-13 |
|
| 18 |
Exter Neil |
Director |
10,000 |
2018-06-08 |
|
| 19 |
Stewart Murray |
Chief Medical Officer |
9,375 |
2021-02-16 |
|
| 20 |
Popovits Kimberly J |
Director |
6,808 |
2026-04-03 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-04-01 |
Mazabraud Yann |
EVP, Head of International |
Ejercicio de Opciones (Venta) |
2,500 |
- |
- |
| 2026-04-01 |
Popovits Kimberly J |
Director |
Concesión de RSU |
6,808 |
- |
- |
| 2026-04-01 |
Popovits Kimberly J |
Director |
Desconocido |
- |
- |
- |
| 2026-03-12 |
Mathers Edward T |
Director |
Otro (Compra) |
4,199 |
- |
- |
| 2026-03-04 |
German Christopher Paul |
Corporate Controller & CAO |
Venta Informativa |
5,614 |
$89.56 |
$502.79K |
| 2026-03-02 |
Mazabraud Yann |
EVP, Head of International |
Concesión de RSU |
35,000 |
$94.94 |
$3.32M |
| 2026-03-02 |
Mathers Edward T |
Director |
Otro (Compra) |
4,198 |
- |
- |
| 2026-03-01 |
German Christopher Paul |
Corporate Controller & CAO |
Ejercicio de Opciones (Venta) |
1,162 |
- |
- |
| 2026-03-02 |
Smith Hunter C |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
6,099 |
$6.80 |
$41.47K |
| 2026-02-19 |
Smith Hunter C |
Chief Financial Officer |
Venta Informativa |
585 |
$103.28 |
$60.42K |
| 2026-02-17 |
Smith Hunter C |
Chief Financial Officer |
Venta Informativa |
200 |
$103.84 |
$20.77K |
| 2026-02-14 |
Mazabraud Yann |
EVP, Head of International |
Ejercicio de Opciones (Venta) |
10,000 |
- |
- |
| 2026-02-11 |
Garfield Alastair |
Chief Scientific Officer |
Concesión de RSU |
16,650 |
- |
- |
| 2026-02-11 |
Shulman Joseph |
Chief Technical Officer |
Concesión de RSU |
15,000 |
- |
- |
| 2026-02-11 |
Cramer Pamela J. |
Chief Human Resources Officer |
Concesión de RSU |
11,650 |
- |
- |
| 2026-02-11 |
Lee Jennifer Kayden |
EVP, Head of North America |
Concesión de RSU |
21,650 |
- |
- |
| 2026-02-11 |
Mazabraud Yann |
EVP, Head of International |
Concesión de RSU |
23,350 |
- |
- |
| 2026-02-11 |
Meeker David P |
President and CEO |
Concesión de RSU |
71,900 |
- |
- |
| 2026-02-11 |
German Christopher Paul |
Corporate Controller & CAO |
Concesión de RSU |
5,215 |
- |
- |
| 2026-02-12 |
Smith Hunter C |
Chief Financial Officer |
Venta Informativa |
100 |
$100.10 |
$10.01K |
| 2026-02-11 |
Smith Hunter C |
Chief Financial Officer |
Concesión de RSU |
25,000 |
- |
- |
| 2026-02-10 |
Smith Hunter C |
Chief Financial Officer |
Venta Informativa |
100 |
$104.76 |
$10.48K |
| 2026-02-05 |
Smith Hunter C |
Chief Financial Officer |
Venta Informativa |
3,381 |
$106.06 |
$358.6K |
| 2026-02-04 |
Smith Hunter C |
Chief Financial Officer |
Venta Informativa |
747 |
$107.67 |
$80.43K |
| 2026-02-01 |
Garfield Alastair |
Chief Scientific Officer |
Retención Fiscal de RSU |
2,026 |
$108.99 |
$220.81K |
